Eledon Pharmaceuticals, Inc. Effective Income Tax Rate Reconciliation, Other Adjustments, Amount
Eledon Pharmaceuticals, Inc. (ELDN) reported Effective Income Tax Rate Reconciliation, Other Adjustments, Amount of $24.00 thousand for the 12-month period ending 2024-12-31, per its 10-K filed 2026-03-19.
Financial Statements › Expense Statement › Income Tax
us-gaap:IncomeTaxReconciliationOtherAdjustments · last filed 2026-03-19
- Eledon Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2024 was $24.00K, a 95.76% decline from fiscal 2023.
- Eledon Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2023 was $566.00K, a 396.49% increase from fiscal 2022.
- Eledon Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2022 was $114.00K, a 21.92% decline from fiscal 2021.
- Eledon Pharmaceuticals, Inc. effective income tax rate reconciliation, other adjustments, amount for fiscal 2021 was $146.00K, a 64.04% increase from fiscal 2020.
| Period end | Effective Income Tax Rate Reconciliation, Other Adjustments, Amount 12 month |
|---|---|
| 2024-12-31 | $24.00K 10-K · filed 2026-03-19 |
| 2023-12-31 | $566.00K 10-K/A · filed 2025-08-14 |
| 2022-12-31 | $114.00K 10-K/A · filed 2024-08-19 |
| 2021-12-31 | $146.00K 10-K · filed 2023-03-30 |
| 2020-12-31 | $89.00K 10-K · filed 2022-03-24 |
| 2019-12-31 | $38.00K 10-K · filed 2021-03-31 |
| 2018-12-31 | $90.00K 10-K · filed 2020-03-17 |
| 2017-12-31 | $43.00K 10-K · filed 2019-03-28 |
| 2016-12-31 | $404.00K 10-K · filed 2018-04-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |